Abstract:Aim: Recombiant human telomerase reverse transcriptase (hTERT)-human IL-18(hIL18) was constructed to investigate its expression and biological function in eukaryotic cells. DCs transfected with hTERT-IL18 acquired stronger telomerase activity and were able to elicit an hTERT-specific cytotoxic T lymphocyte CTL response in vitro.Methods: hIL-18 gene fragment was amplified by Polymerase chain reaction (PCR) and TA cloned. The hIL18 gene was then subcloned into eukaryotic expression vector pcDNA3.1(+) containing human TERM via a linker. The sequence of gene fusion was confirmed using both restrictive enzyme digestion and DNA sequencer. The expression vector with gene fusion was transfected into 3T3 cell line with Lipofectamine 2000. ELISA, Western blot, immunofluorescence stain were performed to determine the expression properties of hTERT-hIL18 in 3T3 cells. Its biological effect on the anti-apoptosis was measured by Flow cytometry and its effect on INF-gamma expression was determined using ELISA. After preparation of dendritic cells, hTERT-hIL18, hTERT, hIL-18 expression vectors were transfected into DCs respectively by electroporation to generate hTERT-specific DCs lines. The peripheral blood mononuclear cells PBMCs were stimulated with different DCs lines to create specific CTL. The response of target cell (leukemia cell line-K562 cell) to hTERT-specific CTL was evaluated by LDH release assay.Results: The human IL-18 gene fragment was amplified from the human mononuclear cells and was inserted into pcDNA3.1(+)/hTERT vector successfully. The correct sequence was proved by both restrictive enzyme digestion and sequencing. The correct open reading frame was also verified. Fusion protein of hTERT-hIL18 was effectively expressed in eukaryotic cells, which was detected by both Western-blotting and immunofluorescence stain. The expressed recombinant fusion protein induced similar levels of INF-gamma to that of native IL-18 protein. FCM assay showed that the transfected fusion protein inhibited the apoptosis, which was consistent with the effects of hTERT as a universal tumor associated antigen. CTL assay shows that hTERT-hIL18 and hTERT gene-transfected DCs stimulated T-cell responses that recognized and lysed tumor target cells of high hTERT expression, whereas DCs transfected with hIL-18 gene didn't induced the response of tumor targets lyses.Conclusion: The Recombinant hTERT-hIL18 fusion protein had both biological activity of hTERT and hIL-18, indicating that this rationally designed protein can be further developed as novel tumor therapeutics. DCs transfected with hTERT-IL18 gene were capable of eliciting a stronger hTERT-specific CTL response in vitro.

Construction of Htert and Cox-2 Dependent Oncolytic Adenovirus

A Novel Single Tetracycline-Regulative Adenoviral Vector for Tumor-Specific Bax Gene Expression and Cell Killing in Vitro and in Vivo

Construction and Characterization of Oncolytic Adenovirus Controlled under Heat Shock Protein70 Gene Promoter*

653. the Controlled Transgene Expression in Oncolytic Adenoviral Vectors with Major Late Promoter for Therapy of Cancer

An Oncolytic Adenovirus Expressing Herpes Simplex Virus-Thymidine Kinase for Targeting Cancer Therapy: an in Vitro Evaluation

A Novel Oncolytic Adenovirus Expressing Escherichia Coli Cytosine Deaminase Exhibits Potent Antitumor Effect on Human Solid Tumors

Oncolytic Adenovirus Programmed by Synthetic Gene Circuit for Cancer Immunotherapy

Anti-tumor effects of an oncolytic adenovirus expressing hemagglutinin-neuraminidase of Newcastle disease virus in vitro and in vivo

Construction and verification of adenovirus containing the hNIS gene under the control of the hTERT core promoter

[Advances in research on oncolytic adenoviruses in tumor therapy]

Construction of Expression Vector of Htert- Hil18 Fusion Gene and Induction of Cytotoxic T Lymphocyte Response Against Htert.

Construction and Identification of Conditionally Replicative Adenovirus under the Control of E2F1 Gene Promoter

The Construction and Characterization of a Novel Adenovirus Vector of Artificial Microrna Targeting EGFR.

Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.

A New Oncolytic Adenoviral Vector Carrying Dual Tumour Suppressor Genes Shows Potent Anti-Tumour Effect

An Oncolytic Adenovirus Expressing Granulocyte Macrophage Colony-Stimulating Factor Shows Improved Specificity and Efficacy for Treating Human Solid Tumors

Potent Anti-Tumor Activity of Telomerase-Dependent and HSV-TK Armed Oncolytic Adenovirus for Non-Small Cell Lung Cancer in Vitro and in Vivo

Conditionally Replicative Adenovirus Vector Carrying Trail Gene For Enhanced Oncolysis Of Human Hepatocellular Carcinoma

The construction of adenovirus expressing TIPE2 and the effect of TIPE2 on the proliferation of colon cancer cells

Construction and verification of adenovirus containing the PUMA gene under the control of the hTER promoter

[Tumor-Targeting Expression of a New Tumor Suppressor Gene HCCS1 and Its Tumor-Selective Inhibitory Effects on Hepatocellular Carcinoma].